The funder and law firm that ran a shareholder class action against Mayne Pharma are seeking deductions that would leave more than half of a $38 million settlement for group members.
An appeals court has backed a decision awarding carriage of a shareholder class action against Downer EDI to two firms that joined their cases, rejecting an argument that it would encourage races to consolidate.
As two class actions against Harvey Norman try to hash out a deal before competing to run the litigation, a judge has issued a warning to other law firms mulling their own actions.
With its new business model of self-funding class actions, Maurice Blackburn can’t get by with an undertaking to indemnify Macquarie for its costs if a case over flex commissions fails.
Applicants in two dismissed class actions against the Commonwealth Bank have secured an order staying an assessment of costs in the failed cases until the outcome of an appeal.
Two failed shareholder class actions against the Commonwealth Bank of Australia want to delay paying the bank’s costs until after their 62-ground appeal is heard.
A judge has criticised the pleadings in class actions against ANZ, Macquarie and Westpac over flexible commission schemes for car dealers, saying they were “inappropriate and unhelpful” in referring to documents in the banking royal commission.
Banks targeted in long-running class actions over flexible commission schemes for car dealers are resisting the plaintiffs’ bid to amend their pleadings to “get around” the defence that certain claims are time-barred.
Generic drug maker Mayne Pharma has resolved a shareholder class action centred on disclosures connected to price-fixing claims by US regulators.
Shareholders of Commonwealth Bank have lodged expected appeals challenging a decision tossing their class actions over alleged lax money laundering compliance, giving the Full Federal Court a chance to clarify when companies must disclose regulatory investigations.